Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress

Biogen (NASDAQ: BIIB) December weekly option implied volatility is at 55, December is at 51; compared to its 52-week range of 29 to 97 into data will be peer reviewed and presented Nov. 29 at the Clinical Trials on Alzheimer's Congress.

You May Also Be Interested In

• Roundhill T-Rex 2X Long Dram Daily (RAM) call put ratio 1.8 calls to 1 put on 17K contracts
• Oracle (ORCL) call put ratio 4.3 calls to 1 put on active option volume of 508K contracts
• Micron Technology (MU) call put ratio 1.2 calls to 1 put with a focus on July 520 and August 540 puts